Question 1

Does BNP Paribas Asset Management Holding own CYTK stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Asset Management Holding holds 827,810 shares of CYTK (Cytokinetics), worth $70.5M.

Question 2

How many shares of CYTK does BNP Paribas Asset Management Holding own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Asset Management Holding holds 827,810 shares of CYTK (Cytokinetics).

Question 3

What is BNP Paribas Asset Management Holding's CYTK position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Asset Management Holding's CYTK position is worth $70.5M.

Question 4

Is BNP Paribas Asset Management Holding buying or selling CYTK?

Accepted Answer

In Q2 2026, BNP Paribas Asset Management Holding increased its CYTK position by 113,466 shares (+15.9%).

Question 5

When did BNP Paribas Asset Management Holding first buy CYTK?

Accepted Answer

BNP Paribas Asset Management Holding first reported CYTK in its Q4 2020 13F and has listed it in 23 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	827,810	+15.9%	$70.5M	0.1%	$85.19	34
2026-Q1	Decreased	714,344	-13.7%	$47.1M	0.1%	$65.91	0
2025-Q4	Increased	827,863	+5.5%	$52.6M	0.1%	$63.54	31
2025-Q3	Increased	785,000	+16.1%	$43.1M	0.1%	$54.96	40
2025-Q2	Increased	676,280	+29.4%	$22.3M	0.1%	$33.04	36
2025-Q1	Increased	522,468	+6.8%	$21M	0.1%	$40.19	30
2024-Q4	Increased	489,362	+49.2%	$23M	0.1%	$47.04	39
2024-Q3	Decreased	328,072	-14.6%	$17.3M	0.0%	$52.80	0